These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

806 related items for PubMed ID: 22086881

  • 1. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
    Barst RJ, McGoon MD, Elliott CG, Foreman AJ, Miller DP, Ivy DD.
    Circulation; 2012 Jan 03; 125(1):113-22. PubMed ID: 22086881
    [Abstract] [Full Text] [Related]

  • 2. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).
    Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS, Frost A, Barst RJ, Badesch DB, Elliott CG, Liou TG, McGoon MD.
    Circulation; 2010 Jul 13; 122(2):164-72. PubMed ID: 20585012
    [Abstract] [Full Text] [Related]

  • 3. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
    Barst RJ, Ivy DD, Foreman AJ, McGoon MD, Rosenzweig EB.
    Am J Cardiol; 2014 Jan 01; 113(1):147-55. PubMed ID: 24176071
    [Abstract] [Full Text] [Related]

  • 4. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
    Sajan I, Manlhiot C, Reyes J, McCrindle BW, Humpl T, Friedberg MK.
    Am Heart J; 2011 Sep 01; 162(3):562-8. PubMed ID: 21884877
    [Abstract] [Full Text] [Related]

  • 5. Sex differences in the diagnosis, treatment, and outcome of patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
    Shapiro S, Traiger GL, Turner M, McGoon MD, Wason P, Barst RJ.
    Chest; 2012 Feb 01; 141(2):363-373. PubMed ID: 21757572
    [Abstract] [Full Text] [Related]

  • 6. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival.
    Humbert M, Yaici A, de Groote P, Montani D, Sitbon O, Launay D, Gressin V, Guillevin L, Clerson P, Simonneau G, Hachulla E.
    Arthritis Rheum; 2011 Nov 01; 63(11):3522-30. PubMed ID: 21769843
    [Abstract] [Full Text] [Related]

  • 7. Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL).
    Preston IR, Roberts KE, Miller DP, Sen GP, Selej M, Benton WW, Hill NS, Farber HW.
    Circulation; 2015 Dec 22; 132(25):2403-11. PubMed ID: 26510696
    [Abstract] [Full Text] [Related]

  • 8. Functional class improvement and 3-year survival outcomes in patients with pulmonary arterial hypertension in the REVEAL Registry.
    Barst RJ, Chung L, Zamanian RT, Turner M, McGoon MD.
    Chest; 2013 Jul 22; 144(1):160-168. PubMed ID: 23429998
    [Abstract] [Full Text] [Related]

  • 9. Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials.
    Benza RL, Gomberg-Maitland M, Naeije R, Arneson CP, Lang IM.
    J Heart Lung Transplant; 2011 Sep 22; 30(9):982-9. PubMed ID: 21531577
    [Abstract] [Full Text] [Related]

  • 10. Treatment of patients with pulmonary arterial hypertension at the time of death or deterioration to functional class IV: insights from the REVEAL Registry.
    Farber HW, Miller DP, Meltzer LA, McGoon MD.
    J Heart Lung Transplant; 2013 Nov 22; 32(11):1114-22. PubMed ID: 24035189
    [Abstract] [Full Text] [Related]

  • 11. Acute pulmonary vasodilator response in paediatric and adult pulmonary arterial hypertension: occurrence and prognostic value when comparing three response criteria.
    Douwes JM, van Loon RL, Hoendermis ES, Vonk-Noordegraaf A, Roofthooft MT, Talsma MD, Hillege HL, Berger RM.
    Eur Heart J; 2011 Dec 22; 32(24):3137-46. PubMed ID: 21893489
    [Abstract] [Full Text] [Related]

  • 12. Validation of the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) pulmonary hypertension prediction model in a unique population and utility in the prediction of long-term survival.
    Cogswell R, Kobashigawa E, McGlothlin D, Shaw R, De Marco T.
    J Heart Lung Transplant; 2012 Nov 22; 31(11):1165-70. PubMed ID: 23062726
    [Abstract] [Full Text] [Related]

  • 13. Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension.
    Douwes JM, Roofthooft MT, Bartelds B, Talsma MD, Hillege HL, Berger RM.
    Int J Cardiol; 2013 Sep 30; 168(2):1370-7. PubMed ID: 23340486
    [Abstract] [Full Text] [Related]

  • 14. Five-Year outcomes of patients enrolled in the REVEAL Registry.
    Farber HW, Miller DP, Poms AD, Badesch DB, Frost AE, Muros-Le Rouzic E, Romero AJ, Benton WW, Elliott CG, McGoon MD, Benza RL.
    Chest; 2015 Oct 30; 148(4):1043-54. PubMed ID: 26066077
    [Abstract] [Full Text] [Related]

  • 15. Portopulmonary hypertension: a report from the US-based REVEAL Registry.
    Krowka MJ, Miller DP, Barst RJ, Taichman D, Dweik RA, Badesch DB, McGoon MD.
    Chest; 2012 Apr 30; 141(4):906-915. PubMed ID: 21778257
    [Abstract] [Full Text] [Related]

  • 16. Prevalence and impact of coronary artery disease in patients with pulmonary arterial hypertension.
    Shimony A, Eisenberg MJ, Rudski LG, Schlesinger R, Afilalo J, Joyal D, Dragatakis L, Hirsch A, Boutet K, Fox BD, Langleben D.
    Am J Cardiol; 2011 Aug 01; 108(3):460-4. PubMed ID: 21600533
    [Abstract] [Full Text] [Related]

  • 17. [Pediatric pulmonary hypertension and pulmonary arterial hypertension secondary to congenital heart diseases].
    Olguntürk R.
    Anadolu Kardiyol Derg; 2010 Aug 01; 10 Suppl 1():50-6. PubMed ID: 20819767
    [Abstract] [Full Text] [Related]

  • 18. Frequency and prognostic significance of hemoptysis in pediatric pulmonary arterial hypertension.
    Roofthooft MT, Douwes JM, Vrijlandt EJ, Berger RM.
    Am J Cardiol; 2013 Nov 01; 112(9):1505-9. PubMed ID: 23972345
    [Abstract] [Full Text] [Related]

  • 19. Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005.
    van Loon RL, Roofthooft MT, Hillege HL, ten Harkel AD, van Osch-Gevers M, Delhaas T, Kapusta L, Strengers JL, Rammeloo L, Clur SA, Mulder BJ, Berger RM.
    Circulation; 2011 Oct 18; 124(16):1755-64. PubMed ID: 21947294
    [Abstract] [Full Text] [Related]

  • 20. Outcomes in children with idiopathic pulmonary arterial hypertension.
    Yung D, Widlitz AC, Rosenzweig EB, Kerstein D, Maislin G, Barst RJ.
    Circulation; 2004 Aug 10; 110(6):660-5. PubMed ID: 15289375
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.